‘Deeply concerns me’: Original prescriber’s alarm over cannabis trends Medicinal cannabis prescription rates are skyrocketing, with sales in the first half of 2024 almost equal to all of 2023 – but it comes amid mounting concern.
Update of ‘leading handbook’ for diabetes support After four years and an evolving type 2 diabetes landscape, the RACGP has launched its refresh of the flagship clinical guideline.
Medical devices impacted by 3G shutdown GPs are being urged to speak to their patients and take ‘necessary precautions’ as essential devices and alarms could be affected.
TGA rejects Alzheimer’s medication due to safety concerns Advocates say the decision not to register lecanemab is a missed opportunity to begin reversing impacts of Alzheimer’s disease.
TGA urges ‘extreme caution’ amid fake Ozempic pen imports GPs are being warned to lookout for the counterfeit pens and are urged to inform their patients, with one person already suffering life-threatening complications.
‘Visionary’ review suggests quicker approval of new medicines New subsidised medication approvals would be streamlined and access made easier for vulnerable populations, under a new health technology plan.
RACGP endorses ‘landmark’ safe deprescribing guide Limited guidance on safely stopping antidepressants is being addressed as new advice for Australian general practice gets the green light.
Concern for rural practices as IV fluid shortage bites The TGA is working to find suitable alternatives, with the unprecedented shortage expected to last at least until the end of the year.
App to provide quick access to living guidelines A new app is on the way to help time-poor GPs access clinical resources at their fingertips, from various sources, from a single platform.
Flagship preventive health guidelines get first update in eight years The RACGP says the 10th edition of its Red Book has undergone rigorous updates to ensure it is accessible and relevant to Australia’s changing healthcare landscape.